ELDN
ELDN
NASDAQ · Biotechnology

Eledon Pharmaceuticals Inc

$2.19
+0.22 (+11.17%)
As of Feb 8, 2:07 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +452.1% upside
Low Target $9.42
Average Target $12.09
High Target $15.53
Current Price $2.19
Current
$2.19
Target
$12.09
$9.42 $12.09 avg $15.53
Scenario Analysis
Bear Case
$9.42
330.1%
Low target
Base Case
$12.09
+452.1%
Avg target
Bull Case
$15.53
+609.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$15.17
-85.6% from high
52-Week Low
$8.95
+-75.5% from low
Target vs 52W High
$12.09
-20.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%